Consistency of Continuous Ambulatory Interstitial Glucose Monitoring Sensors

Abstract

Aims: The abdominal region is the most common location for continuous glucose monitor (CGM) sensor insertion. However, a paucity of post-marketing data is available to demonstrate intra-individual consistency of CGM readings at different abdominal insertion sites. Methods: Healthy adults (fasting glucose (FG) < 5.5 mmol/L; BMI < 30 kg/m2) were recruited and a CGM sensor was placed on each side of the abdomen. Postprandial and continuous 48-h interstitial glucose levels were analyzed. Results: There was no significant difference in the 3-h postprandial glucose (PPG) level derived from the left versus right CGM, which remained non-significant after adjusting for waist circumference or FG. Among the glucose levels recorded over 48-h, values on the left site were greater in 3.6% of the data points (p < 0.05). After adjusting for waist circumference, only 0.5% of the glucose values remained significantly greater on the left (p < 0.05). When adjusted for FG, similar results were observed. For both PPG and 48-h readings, the mean absolute relative difference was not significant between the two abdominal sites. Conclusions: CGM-derived glucose measures were highly consistent between the left and right abdomen during both the postprandial and post-absorptive periods.

Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life—A Narrative Review

“…The measured glucose levels are strongly influenced by numerous factors related to the insertion place [ 71 ]. The abdominal region [ 71 ] is the most common location, followed by the upper arm.…”

“…The measured glucose levels are strongly influenced by numerous factors related to the insertion place [ 71 ]. The abdominal region [ 71 ] is the most common location, followed by the upper arm. Measurements from the right abdominal site tend to be more diminished than those from the left.…”

Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches

“…Many potential nanocarriers were investigated for intrathecal administration: for example, alginate/chitosan composite and maltosyl beta-cyclodextrin for improved delivery efficiency of bupivacaine [97,98]. There are other examples of different nanocarriers administered by intrathecal injection, including polymer-based nanocomplexes [99][100][101][102] and inorganic nanocarriers [103]. However, the disadvantages of intrathecal injection are the risk of brain tissue damage, high changes in the intracranial pressure and low penetration of the drug through the BBB [100,104,105].…”

Metabolic Implications of Diet and Energy Intake during Physical Inactivity

“…Continuous glucose monitoring-Medtronic iPro2® (MedTronic MiniMed, Inc.) continuous glucose monitor (CGM) was inserted in the periumbilical region of the abdomen of each subject and was used to measure interstitial glucose concentrations, as previously described (32). Recent data suggests good agreement between left and right abdominal sensor insertion sites (33). Briefly, during each trial, the CGM was inserted in the same area of the abdomen.…”